Kiora Pharmaceuticals, Inc. (KPRX)

Kiora Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5.64	2.45	5.96	7.85	1.19	3.78
Cash & Short-Term Investments	29.04	2.45	5.96	7.85	1.19	3.78
Cash Growth	437.64%	-58.85%	-24.06%	562.46%	-68.61%	-52.82%
Other Receivables	0.36	2.05	1.37	0.53	0.09	0
Receivables	2.15	2.05	1.37	0.53	0.09	0
Prepaid Expenses	0.18	0.23	0.34	0.61	0.45	0.46
Other Current Assets	0.29	-	-	-	-	0.08
Total Current Assets	31.65	4.74	7.68	8.99	1.73	4.32
Property, Plant & Equipment	0.14	0.11	0.17	0.28	0.11	0.02
Goodwill	-	-	-	-	3.63	1.53
Other Intangible Assets	6.69	0.12	0.14	0.17	0.19	0.22
Long-Term Deferred Charges	-	8.7	10.6	10.6	9.54	3.91
Other Long-Term Assets	0.03	0.05	0.08	0.09	0.1	0.11
Total Assets	38.51	13.71	18.68	20.13	15.3	10.11
Accounts Payable	0.66	0.21	1.01	0.16	0.43	0.21
Accrued Expenses	1.56	1.38	1.84	1.33	1.29	1.12
Current Portion of Long-Term Debt	-	-	-	-	0.21	-
Current Portion of Leases	0.03	0.05	0.11	0.12	0.05	0.08
Other Current Liabilities	1.12	-	0.32	-	-	-
Total Current Liabilities	3.53	1.63	3.27	1.61	1.98	1.41
Long-Term Debt	-	-	-	-	0.28	-
Long-Term Leases	0.04	0.06	-	0.09	0.04	-
Long-Term Deferred Tax Liabilities	0.78	0.78	0.69	0.8	0.73	0.37
Other Long-Term Liabilities	4.13	5.13	3.31	3.05	2.55	1.71
Total Liabilities	8.48	7.6	7.27	5.55	5.57	3.49
Common Stock	0.27	0.08	0.02	0	0.06	0.04
Additional Paid-In Capital	169	153.19	146.04	135.54	116.78	106.69
Retained Earnings	-139.16	-146.98	-134.46	-120.88	-107.11	-100.25
Comprehensive Income & Other	-0.08	-0.18	-0.18	-0.09	-0	0.14
Total Common Equity	30.03	6.11	11.41	14.58	9.73	6.62
Shareholders' Equity	30.03	6.11	11.41	14.58	9.73	6.62
Total Liabilities & Equity	38.51	13.71	18.68	20.13	15.3	10.11
Total Debt	0.07	0.11	0.11	0.21	0.57	0.08
Net Cash (Debt)	28.96	2.35	5.86	7.65	0.61	3.69
Net Cash Growth	438.16%	-59.93%	-23.37%	1150.70%	-83.45%	-53.84%
Net Cash Per Share	8.83	4.36	72.00	285.39	47.93	-
Filing Date Shares Outstanding	3	2.92	0.21	0.04	0.02	0.01
Total Common Shares Outstanding	3	0.86	0.2	0.04	0.02	0.01
Working Capital	28.12	3.1	4.41	7.38	-0.26	2.91
Book Value Per Share	10.01	7.14	57.15	414.44	630.41	584.66
Tangible Book Value	23.34	5.99	11.26	14.41	5.9	4.88
Tangible Book Value Per Share	7.78	7.00	56.43	409.64	382.58	430.63
Machinery	-	0.01	0.15	0.16	0.1	0.08
Leasehold Improvements	-	-	0.02	0.02	0.02	0.02

Source: S&P Capital IQ. Standard template. Financial Sources.